FDA Clears Insulet’s Omnipod 5 for Type 2 Diabetes Management: Stock Surges
Insulet's stock soars 7.5% after FDA clears its automated insulin delivery system for type 2 diabetes management, making Omnipod...
Type 1 diabetes
Lexicon Pharmaceuticals to Cut Staff and Focus on Key Treatments for Cost Savings
In a bid to cut costs by $40 million by 2025, Lexicon Pharmaceuticals plans to slash over 75 jobs,...
vTv Therapeutics Faces Clinical Hold on Diabetes Treatment Study by FDA
TV Anchor: In a shocking turn of events, vTv Therapeutics' shares plummeted 40% after the FDA placed a clinical...
Mason Miller: Baseball’s Exciting Pitcher in an Empty Stadium
Mason Miller, a 25-year-old relief pitcher for the Oakland Athletics, has become one of the most electrifying players in...
vTv Therapeutics Shares Surge on $51 Million Private Placement
**Lead:** Shares of vTv Therapeutics skyrocketed as the company secured $51 million in funding for its Phase 3 study...
Biodexa Acquires Worldwide Licensing Rights for Tolimidone
Biodexa Pharmaceuticals has announced its acquisition of the rights to tolimidone, a potential diabetes treatment, from Adhera Therapeutics. Biodexa...
Biodexa Pharma Shares Double After Licensing Deal for Tolimidone
Biodexa Pharmaceuticals shares have doubled to $5.90 after the company acquired the rights to tolimidone, a potential diabetes treatment,...